March 24 is not a ritual date. It marks the 1882 discovery of the tuberculosis bacterium by Robert Koch—and a reminder that a curable disease still kills on a massive scale.
Tuberculosis spreads through the air. A cough in a crowded room can carry infection far beyond the person who is visibly ill. It mainly attacks the lungs, but it does not stop there. Kidneys, brain, spine—TB can reach them all. Fatigue, fever, weight loss and persistent cough are not minor symptoms; they are warning signs often ignored until it is too late.
Numbers tell a grim story. Thousands die every day. Tens of thousands fall ill daily. This continues despite the availability of effective drugs and a vaccine given in infancy. The problem is not science—it is access, delay, and neglect.
In India, the burden remains among the highest globally. The government has committed to eliminating TB and rolled out free diagnosis and treatment. The National Strategic Plan sets clear targets. But targets do not cure patients. Missed diagnoses, interrupted treatment, and weak follow-up keep transmission alive.
Latent TB is another blind spot. Millions carry the infection without symptoms. They are not infectious yet, but the risk remains. When immunity drops—due to malnutrition, illness, or stress—latent infection turns active. Without systematic screening and preventive therapy, this hidden pool continues to feed new cases.
The disruption caused by COVID-19 exposed fragile health systems. TB testing dropped. Patients skipped treatment. Field outreach slowed. The result: delayed detection and rising risk of drug-resistant TB. These are setbacks that cannot be ignored.
Treatment exists, but it demands discipline. TB therapy runs for months. Missing doses is not a small mistake—it allows the bacteria to survive and mutate. Drug-resistant TB is harder, longer, and costlier to treat. Ensuring adherence is as critical as prescribing the medicine.
Stigma adds another barrier. Many hide symptoms out of fear—of isolation, of lost income, of social judgment. Silence helps the disease spread. Public messaging has to shift from fear to responsibility: early testing protects families and communities.
Ending TB requires direct action. Expand screening in high-risk areas. Strengthen local health workers. Ensure uninterrupted drug supply. Track patients until completion of treatment. Improve nutrition support for vulnerable groups. Use data to identify gaps, not just to report success.
This is not an unsolved problem. It is a mismanaged one. The tools exist. The knowledge exists. What is required is consistent execution.
March 24 should not pass as another awareness event. It should mark measurable progress—more cases detected early, more patients completing treatment, fewer deaths recorded.
TB will not disappear on its own. It will end only when systems work without gaps and responses match the scale of the problem.
